← Back to Clinical Trials
Recruiting NCT07732829

NCT07732829 FlexED: Full Threshold ED Substudy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07732829
Status Recruiting
Phase —
Sponsor Duke University
Condition Eating Disorders
Study Type INTERVENTIONAL
Enrollment 6 participants
Start Date 2026-09-01
Primary Completion 2028-07

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
FlexED

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 6 participants in total. It began in 2026-09-01 with a primary completion date of 2028-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to test whether a new digital intervention decreases eating disorder symptoms in young women with eating disorders by changing how they experience thoughts and feelings about their body. The digital intervention is based on Acceptance and Commitment Therapy (ACT). Participants complete up to 7 digital intervention sessions using their mobile phone that include a character, story line and interactive exercises, games and digital rewards. Researchers will examine the impact of the intervention on participants' ability to respond flexibly to body-image distress or triggers, measuring things like heart rate, eye movements, and reaction time to body-image related words and images, and examine changes in eating disorder symptoms before and after intervention.

Eligibility Criteria

Inclusion Criteria: * Female age 15-25 years * Weight Concerns Scale score of \>=47 * Meets diagnostic criteria for an eating disorder based on the DSM-5 Exclusion Criteria: * Psychosis, substance use disorder, or current suicidal ideation or self-harm * Start or change in psychiatric medications within the past month * Non-English speaking

Contact & Investigator

Central Contact

Rhonda Merwin, PhD

✉ rhonda.merwin@duke.edu

📞 919-681-7231

Frequently Asked Questions

Who can join the NCT07732829 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 25 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07732829 currently recruiting?

Yes, NCT07732829 is actively recruiting participants. Contact the research team at rhonda.merwin@duke.edu for enrollment information.

Where is the NCT07732829 trial being conducted?

This trial is being conducted at Durham, United States.

Who is sponsoring the NCT07732829 clinical trial?

NCT07732829 is sponsored by Duke University. The trial plans to enroll 6 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology